Get the Stockscreener App
1.39
0.00%
0.00
Gri Bio Inc stock is traded at $1.39, with a volume of 35,826.
It is up +0.00% in the last 24 hours and down -29.08% over the past month.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
See More
Previous Close:
$1.39
Open:
$1.39
24h Volume:
35,826
Relative Volume:
0.23
Market Cap:
$3.50M
Revenue:
-
Net Income/Loss:
$-8.26M
P/E Ratio:
-0.0259
EPS:
-53.609
Net Cash Flow:
$-12.17M
1W Performance:
-0.71%
1M Performance:
-29.08%
6M Performance:
-82.60%
1Y Performance:
-84.60%
1-Day Range:
$1.36
$1.40
1-Week Range:
$1.3301
$1.46
52-Week Range:
$1.10
$30.43
Gri Bio Inc Stock (GRI) Company Profile
Name
Gri Bio Inc
Sector
Industry
Phone
(619) 400-1171
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA
Compare GRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
1.39 | 3.50M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | H.C. Wainwright | Buy |
Gri Bio Inc Stock (GRI) Latest News
Reversal indicators forming on GRI Bio Inc. stockMarket Activity Summary & Trade Opportunity Analysis - Newser
Quantitative breakdown of GRI Bio Inc. recent move2025 Top Gainers & Daily Price Action Insights - Newser
Historical volatility pattern of GRI Bio Inc. visualizedWeekly Trade Analysis & High Accuracy Swing Entry Alerts - Newser
Is GRI Bio Inc. forming a reversal pattern2025 Key Highlights & Technical Pattern Alert System - Newser
Strategies to average down on GRI Bio Inc.July 2025 Volume & AI Optimized Trade Strategies - Newser
Custom watchlist performance reports with GRI Bio Inc.Breakout Watch & Free Growth Oriented Trading Recommendations - Newser
How to use a screener to detect GRI Bio Inc. breakoutsMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
Combining price and volume data for GRI Bio Inc.2025 Macro Impact & Daily Stock Momentum Reports - Newser
Using AI based signals to follow GRI Bio Inc.Stock Surge & Community Consensus Stock Picks - Newser
GRI Bio Inc. stock prediction for this weekWeekly Trade Recap & Free Community Consensus Stock Picks - Newser
Published on: 2025-08-30 21:37:20 - Newser
Advanced analytics toolkit walkthrough for GRI Bio Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Is GRI Bio Inc. stock poised for growthWeekly Trade Review & Safe Entry Trade Signal Reports - Newser
Regression analysis insights on GRI Bio Inc. performanceJuly 2025 Review & Fast Gaining Stock Reports - Newser
Developing predictive dashboards with GRI Bio Inc. dataBreakout Watch & Verified Momentum Stock Alerts - Newser
Exit strategy if you’re trapped in GRI Bio Inc.Weekly Investment Summary & Accurate Trade Setup Notifications - Newser
Will GRI Bio Inc. rebound enough to break even2025 EndofYear Setup & Intraday High Probability Alerts - Newser
Does GRI Bio Inc. qualify in momentum factor screening2025 Key Lessons & Weekly Top Gainers Trade List - Newser
Using data models to predict GRI Bio Inc. stock movementJuly 2025 Short Interest & Weekly Return Optimization Alerts - Newser
Risk Off: What is GRI Bio Inc.’s valuation compared to sectorJuly 2025 Patterns & Weekly Consistent Profit Watchlists - sundaytimes.kr
What to expect from GRI Bio Inc. in the next 30 daysJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
Can you recover from losses in GRI Bio Inc.2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
Gri Bio Inc Stock (GRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):